Your browser doesn't support javascript.
loading
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab.
Spira, Alexander; Girard, Nicolas; Krebs, Matthew; Park, Keunchil; Shu, Catherine; Dougherty, Lindsay; Cho, Byoung Chul.
Afiliación
  • Spira A; Virginia Cancer Specialists Research Institute, US Oncology Research, Fairfax, VA, USA.
  • Girard N; Institut Curie, Paris, France.
  • Krebs M; Division of Cancer Sciences, Faculty of Biology, Medicine & Health, The University of Manchester & The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Shu C; Columbia University Medical Center, New York, NY, USA.
  • Dougherty L; Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Future Oncol ; 19(33): 2213-2225, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37589131
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos